Devices today are collecting a large amount of data about us, everything around our lifestyle choices, our environments and even our genetic data. What if treatment and prevention of diseases can be tailored to a specific individual based on the millions of data points we know about you?
Featuring insights from Dr Ngiam Kee Yuan (Group CTO, NUHS), Emanuel Timor (General Partner, Vertex Ventures Israel) and Dr Ori Zelichov (VP Clinical Development, Nucleai)
Find out more about Nucleai: nucleai.ai/
AI Transcripts done by Verbit: verbit.ai/
-----------------------------
Vertex Holdings is a Singapore-based venture capital investment holding company. It provides anchor funding and operational support to a proprietary global network of venture capital funds.
Visit us at www.vertexholdings.com
29 янв 2023
